Imagine a smart health map that predicts if a child or young adult is likely to struggle with obesity based on their genes, environment, and habits. Instead of a one-size-fits-all diet, it creates a custom plan using natural ingredients and Mediterranean diet secrets. It's like having a personalized GPS for health that helps people steer away from chronic diseases before they even start.
Current obesity treatments are often generic and fail to account for individual genetic, metabolic, and environmental differences. This leads to poor long-term outcomes and high costs associated with obesity-related comorbidities.
A Risk Assessment Toolbox (RAT) algorithm for obesity stratification and a set of co-produced creative digital health literacy tools.
If you are a health-tech app developer dealing with low user engagement in generic diet apps — this project developed a Risk Assessment Toolbox (RAT) that provides personalized risk stratification. This allows for the creation of tailored digital interventions based on biological and environmental markers.
If you are a supplement manufacturer dealing with a lack of clinical evidence for anti-obesity products — this project identified molecular targets and evaluated naturally occurring compounds from the Mediterranean diet. This provides a scientific basis for developing targeted metabolic reprogramming products.
If you are a wellness provider dealing with rising obesity-related insurance costs for young employees — this project developed creative health literacy tools and personalized activity programs. These tools can be integrated into corporate health plans to reduce long-term comorbidities.
Based on available project data, there is no mention of pricing or licensing costs for the RAT tool.
Yes, WP4 specifically includes a scalability plan to ensure the health literacy tools and interventions have a broader impact across Europe.
Based on available project data, the IP and licensing terms are not specified, though the project involves 16 partners including 3 industry entities.
The project plans to consolidate its campaign by developing joint programs with healthcare centers, schools, and public authorities.
The project aims for a long-term reduction in obesity prevalence by 2050.
The consortium is heavily research-driven with 12 academic and research institutions (8 universities, 4 research centers) across 8 countries. However, there is a strategic business presence with 3 industry partners (including 2 SMEs), representing a 19% industry ratio, which suggests a clear intent to translate the biological findings into commercial health tools and products.
Contact the Universidade de Coimbra in Portugal
Contact us to explore licensing opportunities for the Risk Assessment Toolbox (RAT).
